Senna-s Softgel Capsule, Liquid Filled
Product Images NDC 84324-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Senna-s Softgel (NDC 84324-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvicare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pl0278-00 Nc Sennoside 8.6mg & Docusate Sodium 50mg Softgel 60ct (Pl0278 00 Nc Sennoside 8.6mg Docusate Sodium 50mg Softgel 60ct)

Pl0278-00 Nc Sennoside 8.6mg & Docusate Sodium 50mg Softgel 60ct (Pl0278 00 Nc Sennoside 8.6mg   Docusate Sodium 50mg Softgel 60ct)
Senna-S Softgel liquid-filled capsules with sennosides 8.6 mg and docusate sodium 50 mg by Nuvicare LLC. The package contains 60 softgels. The front label highlights dual action for gentle, dependable overnight relief. The label includes Drug Facts panels with active ingredients, uses, warnings, directions, and inactive ingredients. The packaging is marked with tamper-evident instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.